Raises additional 16M EUR led by Dawn Biopharma, a platform controlled by KKR, with participation from existing investors. Funds will be used to further strengthen growing pipeline of first in class ADC assets, including lead asset targeting uPARAP. Iyona Rajkomar, Managing Partner at…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.